Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
30 October, 2020 07:45 IST
Natco Pharma launches generic Posaconazole injection in India
Source: IRIS | 11 Jun, 2018, 10.42AM
Rating: NAN / 5 stars.
Comments  |  Post Comment

Natco Pharma announced that it has launched a generic version of Posaconazole Injection, 300 mg/16.7ml, under its brand POSANAT. This is the first time an injection version of this drug available in India. POSANAT will be available in 18.0 mg/ml strength, a formulation for intravenous (IV) use. Posaconazole Injection is sold in the USA market by Merck under its brand name of NOXAFIL.

Posaconazole injection is an antifungal agent & used in patients who are at high risk of developing infections due to being severely immunocompromised, such as associated with stem cell transplant or from chemotherapy.

Shares of the company gained Rs 17.75, or 2.26%, to trade at Rs 804.50. The total volume of shares traded was 25,812 at the BSE (10.28 a.m., Monday).

 Post Comment
Name Email
Security Code type    into this box
Related Articles
Persistent Systems - 29-Oct-2020 21:46
Persistent Systems - 29-Oct-2020 21:46
Titan Company quarterly earnings fall 37.81% - 29-Oct-2020 14:27
Titan Company quarterly net declines 37.81% - 29-Oct-2020 14:24
Titan Company quarterly profit drops 37.81% - 29-Oct-2020 13:58
Sensex falls 225 points - 28-Oct-2020 14:11
sensex trades lower - 28-Oct-2020 13:08
sensex opens higher - 28-Oct-2020 12:20
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer